Letter: Thromboembolism, oral contraceptives, and oestrogen concentration gradient.
作者信息
Mueller H, Stadel B V
出版信息
Lancet. 1975 Mar 22;1(7908):683-4. doi: 10.1016/s0140-6736(75)91785-7.
PMID:47105
Abstract
摘要
相似文献
1
Letter: Thromboembolism, oral contraceptives, and oestrogen concentration gradient.
Lancet. 1975 Mar 22;1(7908):683-4. doi: 10.1016/s0140-6736(75)91785-7.
2
[Oral contraceptives and thromboembolism (author's transl)].
Kokyu To Junkan. 1978 Mar;26(3):212-20.
3
[Lipid metabolism disorders and increased vascular risk due to contraceptive steroids].
Nouv Presse Med. 1976 Apr 23;6(17):1469-72.
4
Estrogen and thromboembolic problems.
Plast Reconstr Surg. 2002 Aug;110(2):713-5. doi: 10.1097/00006534-200208000-00072.
5
Oral contraception and thromboembolism: the role of progestogens.
N Z Med J. 1980 Aug 13;92(665):98, 101.
6
Managing oral contraception.
Practitioner. 1980 Feb;224(1340):179-81.
7
Etiologic factors in the pathogenesis of liver tumors associated with oral contraceptives.
Am J Obstet Gynecol. 1977 Jan 1;127(1):61-6. doi: 10.1016/0002-9378(77)90315-5.
8
Oral contraceptives and thromboembolic disease: effects of lowering oestrogen content.
Lancet. 1980 May 24;1(8178):1097-101. doi: 10.1016/s0140-6736(80)91550-0.
9
[Contraception and arterial hypertension].
Acquis Med Recent. 1977:177-80.
10
Concomitant estrogen use has been alleged to increase the side effects of certain oxidatively-metabolized psychiatric drugs. Are there any estrogen-free oral contraceptives (OCs)?
J Clin Psychopharmacol. 1989 Jun;9(3):233. doi: 10.1097/00004714-198906000-00028.
Zotero 插件